Ultrasound for spleen size in low platelets
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study uses ultrasound to check the size of your spleen (an organ that filters blood) in people who have low platelet counts. The goal is to see if an enlarged spleen is related to your condition, which may help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your low platelet count must be due to conditions like immune thrombocytopenia (ITP), myelodysplastic syndrome (MDS), certain blood cancers (lymphoproliferative disorders), or an autoimmune disease.
- You must not have low red blood cells (anemia) or low white blood cells - only platelets are low.
- You must not be pregnant, nor have thrombocytopenia caused by drugs, heparin, blood transfusions, or blood clotting problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether “TPO” medicines (like eltrombopag or similar drugs) help people age 14 and older with primary immune thrombocytopenia (ITP) who did not respond well to first treatments. It may help raise platelet counts and reduce bleeding, especially when prior therapy hasn’t worked.
This study uses low-energy ultrasound to safely image your spleen. It helps researchers see how the spleen works in healthy, active adults.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
This study looks at how the immune system goes wrong at the very start of two autoimmune conditions in children: ITP (low blood platelets causing bruising) and lupus (which can affect skin, joints, and organs). Researchers will compare blood samples from patients and healthy children to find early signs of disease, with the goal of better understanding and treating these conditions.
This trial looks at whether certain proteins in the blood can help doctors diagnose immune thrombocytopenia (ITP), a condition where your immune system destroys platelets. It may help find a faster, simpler way to confirm ITP.
This study tests drugs called thrombopoietin agonists to help raise platelet levels in adults with ITP. It may help reduce bleeding risk and improve daily life.
Hear when a new Primary Immune Thrombocytopenic Purpura trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.